# Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

> **NCT00003691** · PHASE3 · COMPLETED · sponsor: **Gynecologic Oncology Group** · enrollment: 240 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** cisplatin
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00003691
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-12
- **Primary completion:** 2004-06
- **Final completion:** —
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2013-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003691, "Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00003691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*